US EditionPublished • loading... • Updated
Deep EigenMatics Ranks #1 Globally in AI Drug Discovery, Outpacing All of Big Pharma in 2025 Patent Output
Summary by The AI Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Deep EigenMatics Ranks #1 Globally in AI Drug Discovery, Outpacing All of Big Pharma in 2025 Patent Output
Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 /PRNewswire/ — Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence for drug design, announced today that it has secured the #1 global ranking for new U.S. patent families in AI Drug Discovery methods for 2025. In a landmark first year of operation, Deep EigenMatics has been issued four unique U.S. patent families. …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
